Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mydriatic Microdrops vs Standard Drops for ROP Screening
NCT04623684Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Mar 2020
- Primary completion
- Sep 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of phenylephrine and tropicamide in retinopathy of prematurity (ROP) (2 arms), sponsored by Aristotle University of Thessaloniki. Primary endpoint: Mydriatic efficacy: mm of pupil diameter. Started Mar 2020; status: completed.
02
Drugs
phenylephrinetropicamide
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT04623684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04623684.